| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $9.52 | $190,390.00 | -2.6% | |
| Nov 8, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $9.02 | $180,414.00 | -2.6% | |
| Oct 11, 2019 | Crowley John F67 | Chairman &CEO | Sell | 14,500 | $8.01 | $116,072.50 | -1.9% | |
| Sep 11, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $10.05 | $201,030.00 | -2.6% | |
| Aug 23, 2019 | Whitman Burke W50 | Director | Buy | 4,945 | $10.07 | $49,796.15 | +29.7% | |
| Aug 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $12.54 | $250,736.00 | -2.6% | |
| Jul 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $12.47 | $249,462.00 | -2.6% | |
| Jun 3, 2019 | Raab Michael56 | Director | Sale+OE | 5,000 | $11.16 | $55,776.00 | -36.0% | |
| Jun 3, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $11.15 | $223,072.00 | -2.6% | |
| May 1, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $13.51 | $270,154.00 | -2.6% |